Indaco Capital

Indaco Capital is a principal investment firm established in 2015 and located in Beijing, China. The firm specializes in early-stage investments within the healthcare sector, focusing on areas such as biomedicine, medical devices, and healthcare services. By targeting innovative companies in these industries, Indaco Capital aims to support advancements in healthcare technology and improve patient outcomes.

3 past transactions

Zenshine Pharma

Series A in 2020
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases.

Delova Biotech

Venture Round in 2020
Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States.

Acornmed

Series A in 2020
Acornmed provides tumor genetic testing and detection solutions intended to provide clinical solutions with genomics as the core of tumor precision medicine. It also provides advanced molecular diagnosis for solid and blood tumor genetic testing, enabling cancer patients to receive comprehensive and personalized early detection test results.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.